It is important to note that the development of MG likely involves complex interactions between genetic susceptibility factors and environmental triggers. Environmental factors such as infections, medications, and hormonal changes may play a role in triggering the autoimmune response in genetically susceptible individuals. While genetic factors contribute to the susceptibility to MG, the disease's development is likely multifactorial, involving a combination of genetic predisposition, environmental triggers, and immune dysregulation. Further research is needed to elucidate the specific genetic mechanisms underlying MG and their interactions with environmental factors. Myasthenia gravis research is actively exploring new treatment options beyond traditional medications -Immunotherapies target specific aspects of the immune system involved in MG pathogenesis.